AI entity

Abbott Laboratories

Company

Every one of those 2 sits in a single category, earnings. Dow Jones Industrial Average is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Each story carries 7 original sources on average, compared with 4.6 for the broader beat in this window.

Last mentioned: Aug 27, 2026

Entity pulse

Recent coverage · Abbott Laboratories

2 stories
6 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Abbott Laboratories

Every one of those 2 sits in a single category, earnings. Dow Jones Industrial Average is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Each story carries 7 original sources on average, compared with 4.6 for the broader beat in this window. The 6 average consequence score is below the beat benchmark of 6.7 in the same window. We currently track 2 AI stories that mention Abbott Laboratories, published between July 16, 2026 and July 20, 2026.

Stories tracked
2
Sources per story
7

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 71 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Abbott Laboratories. Shared-story counts are live from our verified record — not editorial picks.

Key Data

ticker
ABT
name
Abbott Laboratories
price
99.75
change
0.89
changePct
0.9

Stories mentioning Abbott Laboratories 2

Earnings Neutral

AI Stock Selloff Deepens: Nasdaq Falls 1.5% as Nvidia Drops 2.4%

AI chip stocks tumbled again on July 16, 2026, with Nvidia falling 2.4% and Micron down 5.6%, dragging the tech-heavy Nasdaq to a 1.5% loss. The selloff extends a weeks-long correction fueled by valuation worries and questions over the sustainability of AI hardware demand.

8 sources

Abbott Laboratories is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.